Search Within

Neil Jayendra Shah

Formats
  1. Meeting Abstract (56)
  2. Journal Article (32)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (91)
  2. Genitourinary Oncology Service (91)
  3. Solid Tumor Oncology Division (91)
  4. Hematologic Malignancies, Division of (36)
  5. Weinberg Fellows (35)
  6. Population Sciences Research Program (28)

More Groups

People
  1. Robert Motzer (39)
  2. Martin Voss (28)
  3. Ritesh Kotecha (28)
  4. Maria Carlo (24)
  5. Darren Feldman (22)
  6. David Aggen (22)

More People

Years
  1. 2025 (16)
  2. 2024 (19)
  3. 2023 (22)
  4. 2022 (18)
  5. 2021 (13)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (47)
  2. Journal for ImmunoTherapy of Cancer (7)
  3. Cancers (4)
  4. The Oncologist (4)
  5. Annals of Oncology (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (49)
  2. Oxford University Press (8)
  3. Biomed Central Ltd (7)
  4. MDPI (5)
  5. American Association for Cancer Research (3)
  6. Elsevier BV (3)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma
    Journal Article

    Beckermann, K. E.; Shah, N. J.; Campbell, M. T.; Haas, N. B.; Nelson, A.; Ornstein, M. C.; Mao, S.; Keshava-Prasad, H. S.; Hammers, H.; Gao, X.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions
    Journal Article

    Zhang, Y.; Lev-Ari, S.; Zaemes, J.; Pia, A. D.; DeAgresta, B.; Gupta, S.; Marki, A.; Zemel, R.; Ip, A.; Alaoui, A.; more...
    JAMIA Open (2025)

    Fulltext@MSK | Save
  • Patient-reported experience with an immunotherapy telehealth platform
    Meeting Abstract

    Daly, R. M.; Malling, C.; Dagostino, A.; Bange, E. M.; Preeshagul, I. R.; Aggen, D. H.; Carlo, M.; Chen, M. F.; Eng, J.; Ng, K. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Use of a large language model (LLM) for pan-cancer automated detection of anti-cancer therapy toxicities and translational toxicity research
    Meeting Abstract

    Bakouny, Z.; Ahmed, N.; Fong, C.; Rahman, A.; Perea-Chamblee, T.; Pichotta, K.; Waters, M.; Fu, C.; Jeng, M. Y.; Lee, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • KEAP1 mutated renal cell carcinoma (RCC): Characterization of an emerging molecularly defined RCC subtype
    Meeting Abstract

    Carlo, M.; Chen, Y. B.; Knezevic, A.; Zong, G.; Bakouny, Z.; Kemel, Y.; Latham, A.; Liu, Y. L.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Esophagectomy may have a role in stage IV esophageal adenocarcinoma
    Journal Article

    Sewell, M.; Toumbacaris, N.; Tan, K. S.; Bahadur, N.; Philip, J.; Shah, N. J.; Niederhausern, A.; Tavarez Martinez, C.; Zheng, H.; Boerner, T.; more...
    Journal of Thoracic and Cardiovascular Surgery (2025)

    Fulltext@MSK | Save
  • FOXA2 promotes metastatic competence in small cell lung cancer
    Journal Article

    Kawasaki, K.; Salehi, S.; Zhan, Y. A.; Chen, K.; Lee, J. H.; Salataj, E.; Zhong, H.; Manoj, P.; Kinyua, D.; Mello, B. P.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
    Journal Article

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N. M.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post-immune-oncology and vascular endothelial growth factor receptor targeted therapies
    Journal Article

    Shah, N. J.; Sura, S.; Shinde, R.; Shi, J.; Bupathi, M.; Vickery, D.; Motzer, R. J.
    Cancers (2025)

    Fulltext@MSK | Save
  • A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with advanced or metastatic renal cell carcinoma (NCT06234605)
    Meeting Abstract

    Shah, N. J.; Bupathi, M.; Garmezy, B.; McKay, R. R.; Ornstein, M. C.; Figlin, R. A.; Picus, J.; Rank, B. H.; Barata, P. C.; Hammers, H. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save